TRAVERE THERAPEUTICS, INC. Number of Operating Segments
TRAVERE THERAPEUTICS, INC. (TVTX) reported Number of Operating Segments of 1 segment for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfOperatingSegments · last filed 2026-08-04
- TRAVERE THERAPEUTICS, INC. number of operating segments for the quarter ending 2026-03-31 was 1.00 segment, a 0.00% change year-over-year.
- TRAVERE THERAPEUTICS, INC. number of operating segments for the quarter ending 2025-03-31 was 1.00 segment.
- TRAVERE THERAPEUTICS, INC. number of operating segments for fiscal 2025 was 1.00 segment, a 0.00% change from fiscal 2024.
- TRAVERE THERAPEUTICS, INC. number of operating segments for fiscal 2024 was 1.00 segment, a 0.00% change from fiscal 2023.
- TRAVERE THERAPEUTICS, INC. number of operating segments for fiscal 2023 was 1.00 segment, a 0.00% change from fiscal 2022.
- TRAVERE THERAPEUTICS, INC. number of operating segments for fiscal 2022 was 1.00 segment, a 0.00% change from fiscal 2021.
| Period end | Number of Operating Segments 3 month | Number of Operating Segments 6 month | Number of Operating Segments 9 month | Number of Operating Segments 12 month |
|---|---|---|---|---|
| 2026-06-30 | 1.00 segment 10-Q · filed 2026-08-04 | |||
| 2026-03-31 | 1.00 segment 10-Q · filed 2026-05-04 | |||
| 2025-12-31 | 1.00 segment 10-K · filed 2026-02-19 | |||
| 2025-09-30 | 1.00 segment 10-Q · filed 2025-10-30 | |||
| 2025-06-30 | 1.00 segment 10-Q · filed 2025-08-06 | |||
| 2025-03-31 | 1.00 segment 10-Q · filed 2025-05-01 | |||
| 2024-12-31 | 1.00 segment 10-K · filed 2025-02-21 | |||
| 2023-12-31 | 1.00 segment 10-K · filed 2024-02-20 | |||
| 2022-12-31 | 1.00 segment 10-K · filed 2023-02-23 | |||
| 2021-12-31 | 1.00 segment 10-K · filed 2022-02-24 | |||
| 2020-12-31 | 1.00 segment 10-K · filed 2021-03-01 | |||
| 2019-12-31 | 1.00 segment 10-K · filed 2020-02-24 | |||
| 2018-12-31 | 1.00 segment 10-K · filed 2019-02-26 | |||
| 2017-12-31 | 1.00 segment 10-K · filed 2018-07-06 | |||
| 2016-12-31 | 1.00 segment 10-K · filed 2017-03-01 | |||
| 2015-12-31 | 1.00 segment 10-K · filed 2016-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |